LINCOLNSHIRE, ILL. – Oct. 11, 2017 –
Sysmex America, Inc. announced today that it has been recognized by Forbes magazine’s 2017 list of the world’s most innovative companies for the second consecutive year.
Sysmex was the highest ranked company in the global “health care equipment & services” category, and was named the 27th most innovative company overall in the world, across all categories. In 2016, Sysmex was named the 28th most innovative company.
Joining Sysmex among the top 30 are companies such as Tesla, Amazon, Netflix, Adobe Systems, Marriott International, Rakuten and LG.
“The continuous innovation in our products, testing and quality processes, and in how we partner with our customers, have powered improvements in health care for millions of patients,” said Ralph Taylor, chief executive officer. “Our employees are the most innovative part of Sysmex, and their ingenuity and passion for creating unique and innovative value make it possible for us to shape the future of healthcare.”
Sysmex is the leading developer of best-in-class, in vitro diagnostic hematology and clinical laboratory products in more than 190 countries. The company’s many innovations include being the first to:
- Market an immature granulocyte count
- Introduce diode laser technology to hematology
- Automate reticulocyte counting using fluorescent flow cytometry
In addition to inventive solutions, product testing and customer support, Sysmex invests in new manufacturing processes that are both efficient and environmentally friendly. For example, Sysmex America’s recently-modernized reagent factory in Mundelein, Ill. has increased production capacity by 80 percent on its existing facility.
Securing a place on Forbes’ most innovative companies list is based on investors’ independent, objective calculations of companies’ “innovation premium,” or the difference between their market capitalization and the net present value of cash flows from existing businesses (based on a proprietary algorithm from Credit Suisse HOLT). The difference between them is the bonus given by equity investors after reviewing seven years or more of the company’s financial data. Companies’ historical and forward return-on-investment, reinvestment rate and other mathematical algorithms are applied to develop the final rankings. A more detailed explanation of Forbes’ ranking methodology can be found by clicking here
About Sysmex America
Sysmex America, Inc. distributes and supports a diverse portfolio of best-in-class, in vitro diagnostic hematology and clinical laboratory products in the U.S., Canada and Latin America. It is the regional entity of Sysmex Corporation, located in Kobe, Japan, a trusted world leader in clinical laboratory solutions that optimize efficiency, operations and financial performance in the lab. Sysmex is reshaping the health care of tomorrow at the clinical laboratory level by transcending the boundaries of diagnostic science and serving as the pulse of reliable, accountable care. For more information about Sysmex America, visit http://www.sysmex.com/us.
Forbes recently celebrated its centennial anniversary, and through those 100 years, has championed entrepreneurial capitalism while reinventing its medium, technology and platform to reach today’s audience through a diverse base of more than 2,000 contributors and staff writers. It is the top-ranked publication among “c-suite” executives, and its forbes.com website attracts 50 million viewers per month, and 34 million social media followers.
Forbes Media, a global media, branding and technology company, offers a focus on news and information about business, investing, technology, entrepreneurship, leadership and affluent lifestyles. The company publishes Forbes, Forbes Asia and Forbes Europe magazines, as well as Forbes.com. The Forbes brand today reaches more than 94 million people worldwide through its magazines and 38 licensed local editions around the globe, Forbes.com, TV, conferences, research, social and mobile platforms.